 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | PharmaSecure |
| Street 1: | AB-1, 2nd Floor, Community Centre, Safdarjung Enclave |
| Street 2: | |
| City: | New Delhi |
| Province: | |
| Post Code: | 110029 |
| Country: | India |
| Phone: | 01140588772 |
| Organization Email: | rsingh@pharmasecure.com |
| Web Site: | http://www.pharmasecure.com |
| Other Online Presence: | |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | Private sector |
| Is your organization legally registered in your country: | Yes |
| If yes, please enter your registration number: | |
| Organization Type - Primary: | Private Sector |
| Organization Type - Secondary: | Company |
| Organization Description: | |
| Mission: To empower consumers in at-risk LMIC countries with low cost mobile based tools with access to mobile based healthcare services including access to genuine quality controlled medications. Main Focus: Increase access to authentic medications globally Interest in TB: Ever since the beginning PharmaSecure has focused its activities to support medications that are essential to the public health system in India. We have been working with leading manufacturers of Anti-TB medications in India to ensure genuine medicines are reaching to those in need and therefore enabling a good heath outcome. This is evident from our portfolio of essential TB drugs covered for India. Our activities in TB control: India has a high TB burden and a majority of that problem exists in the private sector. PharmaSecure has been working to introduce low cost scalable solutions that help identify TB patients and then subsequently work with patients to help them complete their TB treatment as prescribed by providing adherence interventions. As a result of this PharmaSecure has been one of the recipients of the Grand Challenges in TB Control grant from the Bill & Melinda Gates Foundation and USAID. Given the total number of anti-TB products we cover in the private secctor (approx 200mn), PharmaSecure has the potential to identify a large number of patients at a low cost and bring them within the scope of TB progammes in the country. We wish to scale this solution to other at-risk geographies globally. |
|
| Do you know about the UNHLM declaration: | |
Specializations / Areas of Work | |
|
Advocacy Technical Assistance |
Other Organization Information | |
| Total number of staff in your organization: | 26 - 50 |
| Number of full-time staff who are directly involved with TB: | 1 - 5 |
| Number of part-time staff who are directly involved with TB: | 1 - 5 |
| Number of volunteers who are directly involved with TB: | 0 |
| How did you hear about the Stop TB Partnership: | Attendance at a TB related event |
| If you were informed or referred by another partner of the Stop TB Partnership please tell us who: | |
| Why do you wish join the Stop TB Partnership: | Involvement in Stop TB Working Groups |
| Are you a member of a Stop TB national partnership: | No |
| Are you in contact with your national TB programme: | Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| PharmaSecure is complementing India's national T control plan by: 1. Helping identify TB patients who are currently invisible to the national TB control plan 2. By engaging with these patients, we are able to help the national TB plan reach out to patients with a proven low cost highly scalable platform to affect adherence to treatment. 3. Automatic adherence notifications from TB patients from all over the country; therefore reducing the burden on the national healthcare infrastructure. |
|
Geographical Reach | |
| Which country is your headquarters located in: | United States of America |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
India Nigeria Pakistan |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
TB Care Delivery: Treatment supervision and patient support: PharmaSecure through its mobile based platform is able to reach out and counsel TB patients towards adhering to their individual TB treatments. This is achieved by multiple modes on the mobile phones and customized to each patient individually. Monitoring and Evaluation: We are able to monitor in an almost real-time basis the adherence to treatment amongst the patients on the platform. This enables to give an accurate picture of the treatment outcomes and challenges faced by patients in treatment completion. Therefore following it up with solutions and course corrections to retrieve patients onto treatment. Research: By virtue of having access to large number of patients using our platform, we can enable operational research of the nature of identifying the most effective intervention to promote adherence to anti-TB treatments. |
|
Declaration | |
| Declaration of interests: No conflicts of interest were delacred. | |
| Application date: | October 29, 2015 |
| Last updated: | May 14, 2018 |